BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10668466)

  • 1. Regulation of transglutaminases by nitric oxide.
    Bernassola F; Rossi A; Melino G
    Ann N Y Acad Sci; 1999; 887():83-91. PubMed ID: 10668466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase.
    Lai TS; Hausladen A; Slaughter TF; Eu JP; Stamler JS; Greenberg CS
    Biochemistry; 2001 Apr; 40(16):4904-10. PubMed ID: 11305905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras.
    Hettasch JM; Peoples KA; Greenberg CS
    J Biol Chem; 1997 Oct; 272(40):25149-56. PubMed ID: 9312126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of clotting factor XIII activity by nitric oxide.
    Catani MV; Bernassola F; Rossi A; Melino G
    Biochem Biophys Res Commun; 1998 Aug; 249(1):275-8. PubMed ID: 9705871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific colorimetric assay for measuring transglutaminase 1 and factor XIII activities.
    Hitomi K; Kitamura M; Alea MP; Ceylan I; Thomas V; El Alaoui S
    Anal Biochem; 2009 Nov; 394(2):281-3. PubMed ID: 19646949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: role of transglutaminases.
    Pistea A; Bakker EN; Spaan JA; Hardeman MR; van Rooijen N; VanBavel E
    J Vasc Res; 2008; 45(1):10-8. PubMed ID: 17898543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase 2 induces nitric oxide synthesis in BV-2 microglia.
    Park KC; Chung KC; Kim YS; Lee J; Joh TH; Kim SY
    Biochem Biophys Res Commun; 2004 Oct; 323(3):1055-62. PubMed ID: 15381106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assays for transglutaminases in cell death.
    Melino G; Candi E; Steinert PM
    Methods Enzymol; 2000; 322():433-72. PubMed ID: 10914039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous activity assay of two transglutaminase isozymes, blood coagulation factor XIII and transglutaminase 2, by use of fibrinogen arrays.
    Kwon MH; Jung SH; Kim YM; Ha KS
    Anal Chem; 2011 Nov; 83(22):8718-24. PubMed ID: 21961727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GTP-binding-defective forms of tissue transglutaminase trigger cell death.
    Datta S; Antonyak MA; Cerione RA
    Biochemistry; 2007 Dec; 46(51):14819-29. PubMed ID: 18052077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene disruption of tissue transglutaminase.
    De Laurenzi V; Melino G
    Mol Cell Biol; 2001 Jan; 21(1):148-55. PubMed ID: 11113189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two isoforms of tissue transglutaminase mediate opposing cellular fates.
    Antonyak MA; Jansen JM; Miller AM; Ly TK; Endo M; Cerione RA
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18609-14. PubMed ID: 17116873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide inhibits cornified envelope formation in human keratinocytes by inactivating transglutaminases and activating protein 1.
    Rossi A; Catani MV; Candi E; Bernassola F; Puddu P; Melino G
    J Invest Dermatol; 2000 Oct; 115(4):731-9. PubMed ID: 10998152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival.
    Kim SJ; Kim KH; Ahn ER; Yoo BC; Kim SY
    Amino Acids; 2013 Jan; 44(1):73-80. PubMed ID: 21960143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of in situ activation of transglutaminase during apoptosis: correlation with the cell cycle phase by multiparameter flow and laser scanning cytometry.
    Grabarek J; Ardelt B; Kunicki J; Darzynkiewicz Z
    Cytometry; 2002 Oct; 49(2):83-9. PubMed ID: 12357464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Catalytic Activity of Transglutaminases in the Context of Autophagic Responses.
    D'Eletto M; Farrace MG; Piacentini M; Rossin F
    Methods Enzymol; 2017; 587():511-520. PubMed ID: 28253975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
    Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness.
    Santhanam L; Tuday EC; Webb AK; Dowzicky P; Kim JH; Oh YJ; Sikka G; Kuo M; Halushka MK; Macgregor AM; Dunn J; Gutbrod S; Yin D; Shoukas A; Nyhan D; Flavahan NA; Belkin AM; Berkowitz DE
    Circ Res; 2010 Jul; 107(1):117-25. PubMed ID: 20489165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+: a stabilizing component of the transglutaminase activity of Galphah (transglutaminase II).
    Lee SC; Kim JH; Park ES; Kim DK; Kim YG; Yun HY; Kwon NS; Im MJ; Baek KJ
    Mol Cells; 2003 Dec; 16(3):285-90. PubMed ID: 14744016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasticity and stabilization of neuromuscular and CNS synapses: interactions between thrombin protease signaling pathways and tissue transglutaminase.
    Festoff BW; Suo Z; Citron BA
    Int Rev Cytol; 2001; 211():153-77. PubMed ID: 11597003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.